Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -156.97% is 212% below its 5-year average of -50.32%, near the low end of its 5-year range (-156.97%–-17.40%).
As of the fiscal period ended Tuesday, June 30, 2026. 40.33% below its 12-month average of -111.86%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -156.97%.
RETURN ON INVESTED CAPITAL (ROIC)
-156.97%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-111.86%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-69.13%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-50.32%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-40.33%
CURRENT VS 3Y AVG
-127.06%
CURRENT VS 5Y AVG
-211.92%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.66%
median of 837 covered companies
CURRENT VS SECTOR MEDIAN
-340.18%
vs the sector median at left
Werewolf Therapeutics, Inc.
Market Cap
$44.72M
Return on Invested Capital (ROIC)
-156.97%
TTM Avg
-111.86%
3Y Avg
-69.13%
5Y Avg
-50.32%
Market Cap
$44.71M
Return on Invested Capital (ROIC)
2.80%
TTM Avg
30.48%
3Y Avg
30.48%
5Y Avg
-223.44%
Market Cap
$44.02M
Return on Invested Capital (ROIC)
-78.42%
TTM Avg
-44.92%
3Y Avg
-51.52%
5Y Avg
-66.63%
Market Cap
$45.73M
Return on Invested Capital (ROIC)
-192.99%
TTM Avg
-98.03%
3Y Avg
-92.21%
5Y Avg
-72.34%
Market Cap
$42.99M
Return on Invested Capital (ROIC)
-59.93%
TTM Avg
-52.27%
3Y Avg
-45.27%
5Y Avg
-36.51%
Market Cap
$42.83M
Return on Invested Capital (ROIC)
-127.36%
TTM Avg
-34.70%
3Y Avg
-36.91%
5Y Avg
-31.07%
Market Cap
$46.69M
Return on Invested Capital (ROIC)
-18.61%
TTM Avg
-27.70%
3Y Avg
-37.95%
5Y Avg
-31.69%
Market Cap
$42.72M
Return on Invested Capital (ROIC)
-123.47%
TTM Avg
-72.55%
3Y Avg
-56.84%
5Y Avg
-50.77%
Market Cap
$42.26M
Return on Invested Capital (ROIC)
-72.12%
TTM Avg
-128.00%
3Y Avg
-128.00%
5Y Avg
-128.00%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Werewolf Therapeutics, Inc. (HOWL) | $44.72M | -156.97% | -111.86% | -69.13% | -50.32% |
| SANUWAVE Health Inc. (SNWV)vs › | $44.71M | 2.80% | 30.48% | 30.48% | -223.44% |
| DarioHealth Corp. (DRIO)vs › | $44.02M | -78.42% | -44.92% | -51.52% | -66.63% |
| Celularity Inc. (CELU)vs › | $45.73M | -192.99% | -98.03% | -92.21% | -72.34% |
| CVRx, Inc. (CVRX)vs › | $42.99M | -59.93% | -52.27% | -45.27% | -36.51% |
| Nano-X Imaging Ltd. (NNOX)vs › | $42.83M | -127.36% | -34.70% | -36.91% | -31.07% |
| Instil Bio, Inc. (TIL)vs › | $46.69M | -18.61% | -27.70% | -37.95% | -31.69% |
| Rapid Micro Biosystems, Inc. (RPID)vs › | $42.72M | -123.47% | -72.55% | -56.84% | -50.77% |
| Filana Therapeutics, Inc. (FLNA)vs › | $42.26M | -72.12% | -128.00% | -128.00% | -128.00% |
| BioStem Technologies, Inc. (BSEM)vs › | $41.95M | -80.92% | 33.73% | -139.74% | -139.74% |
ROIC
-157.0%
ROE
-212.4%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -156.97% |
| 2026-03-31 | -106.86% |
| 2025-12-31 | -98.69% |
| 2025-09-30 | -105.27% |
| 2025-06-30 | -91.49% |
| 2025-03-31 | -77.88% |
| 2024-12-31 | -65.86% |
| 2024-09-30 | -51.90% |
| 2024-06-30 | -41.01% |
| 2024-03-31 | -27.04% |
| 2023-12-31 | -24.98% |
| 2023-09-30 | -24.89% |
| 2023-06-30 | -25.85% |
| 2023-03-31 | -30.52% |
| 2022-12-31 | -41.14% |
| 2022-09-30 | -42.01% |
| 2022-06-30 | -42.78% |
| 2022-03-31 | -37.76% |
| 2021-12-31 | -29.92% |
| 2021-09-30 | -23.21% |
| 2021-06-30 | -17.40% |
| 2021-03-31 | -30.90% |
| 2020-12-31 | -24.59% |
